186 related articles for article (PubMed ID: 15326162)
1. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
Guo Y; Smith K; Petris MJ
J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
[TBL] [Abstract][Full Text] [Related]
2. Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter.
Guo Y; Smith K; Lee J; Thiele DJ; Petris MJ
J Biol Chem; 2004 Apr; 279(17):17428-33. PubMed ID: 14976198
[TBL] [Abstract][Full Text] [Related]
3. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
Liang ZD; Stockton D; Savaraj N; Tien Kuo M
Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
[TBL] [Abstract][Full Text] [Related]
5. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.
Ma G; Wu Q; Wu X; Arnesano F; Natile G; Sletten E; Liu Y
J Inorg Biochem; 2015 Dec; 153():239-246. PubMed ID: 26235215
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
[TBL] [Abstract][Full Text] [Related]
7. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
Du X; Wang X; Li H; Sun H
Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
[TBL] [Abstract][Full Text] [Related]
8. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
Howell SB; Safaei R; Larson CA; Sailor MJ
Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
[TBL] [Abstract][Full Text] [Related]
9. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1.
Petris MJ; Smith K; Lee J; Thiele DJ
J Biol Chem; 2003 Mar; 278(11):9639-46. PubMed ID: 12501239
[TBL] [Abstract][Full Text] [Related]
10. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
Kuo MT; Fu S; Savaraj N; Chen HH
Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
[TBL] [Abstract][Full Text] [Related]
11. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
[TBL] [Abstract][Full Text] [Related]
12. Overcoming platinum drug resistance with copper-lowering agents.
Chen HH; Kuo MT
Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
[TBL] [Abstract][Full Text] [Related]
13. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
Ivy KD; Kaplan JH
Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
[TBL] [Abstract][Full Text] [Related]
14. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ
J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160
[TBL] [Abstract][Full Text] [Related]
15. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
Larson CA; Adams PL; Jandial DD; Blair BG; Safaei R; Howell SB
Biochem Pharmacol; 2010 Aug; 80(4):448-54. PubMed ID: 20451502
[TBL] [Abstract][Full Text] [Related]
16. Rate and regulation of copper transport by human copper transporter 1 (hCTR1).
Maryon EB; Molloy SA; Ivy K; Yu H; Kaplan JH
J Biol Chem; 2013 Jun; 288(25):18035-46. PubMed ID: 23658018
[TBL] [Abstract][Full Text] [Related]
17. The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
Larson CA; Adams PL; Blair BG; Safaei R; Howell SB
Mol Pharmacol; 2010 Sep; 78(3):333-9. PubMed ID: 20519567
[TBL] [Abstract][Full Text] [Related]
18. Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.
Crider SE; Holbrook RJ; Franz KJ
Metallomics; 2010 Jan; 2(1):74-83. PubMed ID: 21072377
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of hCTR1, the human copper uptake protein.
Eisses JF; Kaplan JH
J Biol Chem; 2002 Aug; 277(32):29162-71. PubMed ID: 12034741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]